Comparison of COVID-19 home-testers vs. laboratory-testers in New York State (excluding New York City), November 2021 to April 2022
Vajeera Dorabawila(New York State Department of Health), Eli S. Rosenberg(University at Albany, State University of New York), Jamie Sommer(University of South Florida), Emily Lutterloh(Kentucky Department for Public Health), Virgile Barnes(New York State Department of Health), Rebecca Hoen(New York State Department of Health), Byron Backenson(New York State Department of Health), Nirmala Ramesh(New York State Department of Health), Amy Robbins, Dina Hoefer(New York State Department of Health)
Cited by 9
Related Papers
H1N1 2009 influenza virus infection during pregnancy in the USA
|The Lancet|2009|1.4k
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey
|The Lancet Infectious Diseases|2018|307
COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State—March 2020
|Clinical Infectious Diseases|2020|187
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection
|Critical Care|2007|166
Notes from the Field: Ongoing Transmission of <i>Candida auris</i> in Health Care Facilities — United States, June 2016–May 2017
|MMWR Morbidity and Mortality Weekly Report|2017|163